Aranesp

In the US, Aranesp (darbepoetin alfa systemic) is a member of the drug class recombinant human erythropoietins and is used to treat Anemia Associated with Chronic Renal Failure and Anemia - Chemotherapy Induced.

US matches:

• Aranesp


• Aranesp Albumin Free


• Aranesp SureClick

UK matches:

• ARANESP PFS
• Aranesp SureClick
• ARANESP PFS (SPC)
• Aranesp SureClick (SPC)

Ingredient matches for Aranesp

Darbepoetin Alfa

Darbepoetin Alfa is reported as an ingredient of Aranesp in the following countries:

• Australia


• Austria


• Bahrain


• Belgium


• Bulgaria


• Canada


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Luxembourg


• Netherlands


• Norway


• Oman


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Spain


• Sweden


• Switzerland


• Taiwan


• Tunisia


• Turkey


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.